Cargando…
Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines
IMPORTANCE: Extremely preterm (EP) infants frequently receive opioids and/or benzodiazepines, but these drugs’ association with neurodevelopmental outcomes is poorly understood. OBJECTIVES: To describe the use of opioids and benzodiazepines in EP infants during neonatal intensive care unit (NICU) ho...
Autores principales: | Puia-Dumitrescu, Mihai, Comstock, Bryan A., Li, Sijia, Heagerty, Patrick J., Perez, Krystle M., Law, Janessa B., Wood, Thomas R., Gogcu, Semsa, Mayock, Dennis E., Juul, Sandra E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264640/ https://www.ncbi.nlm.nih.gov/pubmed/34232302 http://dx.doi.org/10.1001/jamanetworkopen.2021.15998 |
Ejemplares similares
-
Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2022) -
Predicting 2-year neurodevelopmental outcomes in extremely preterm infants using graphical network and machine learning approaches
por: Juul, Sandra E., et al.
Publicado: (2022) -
Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
por: Juul, Sandra E., et al.
Publicado: (2022) -
Contemporary Definitions of Infant Growth Failure and Neurodevelopmental and Behavioral Outcomes in Extremely Premature Infants at Two Years of Age
por: Strobel, Katie, et al.
Publicado: (2023) -
Patterns of Infections among Extremely Preterm Infants
por: Perez, Krystle, et al.
Publicado: (2023)